The assessment and management of insomnia in primary care

BMJ

Volumn 342, Issue 7809, 2011, Pages

  Falloon, Karen ^a   Arroll, Bruce ^a   Elley, C Raina ^a   Fernando III, Antonio ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BENZODIAZEPINE; CLONAZEPAM; ESZOPICLONE; HYPNOTIC AGENT; MELATONIN; TEMAZEPAM; TRIAZOLAM; VALERIAN; ZOLPIDEM; ZOPICLONE; HYPNOTIC SEDATIVE AGENT;

ANAMNESIS; ANTICHOLINERGIC SYNDROME; ANXIETY; COGNITIVE THERAPY; DAYTIME SOMNOLENCE; DEPRESSION; DISEASE CLASSIFICATION; HUMAN; INSOMNIA; PARASOMNIA; PHYSICAL EXAMINATION; POLYSOMNOGRAPHY; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SEDATION; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION; SLEEP QUALITY; SLEEP TIME; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN; PATIENT REFERRAL; PRIMARY HEALTH CARE;

HUMANS; HYPNOTICS AND SEDATIVES; PHYSICAL EXAMINATION; POLYSOMNOGRAPHY; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 79957964461     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d2899     Document Type: Review

References (35)

1. Morphy H, Dunn KM, Lewis M, Boardman HF, Croft PR, Morphy H, et al. Epidemiology of insomnia: a longitudinal study in a UK population. Sleep 2007;30:274-80. (Pubitemid 46494402)
2. Arroll B, Fernando A, Falloon K, Warman G, Goodyear-Smith F. Sleepless in Seattle? Finding patients with primary insomnia using the Auckland Sleep Questionnaire. North American Primary Care Research Group Seattle, 2010.
3. Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 1997;154:1417-23. (Pubitemid 27415610)
4. American Sleep Disorders Association. International Classification of Sleep Disorders, second edition: diagnostic and coding manual. American Sleep Disorders Association, 2005.
5. Kuppermann M, Lubeck D, Mazonson P, Patrick D, Stewart A, Buesching D, et al. Sleep problems and their correlates in a working population. J Gen Int Med 1995;10:25-32.
6. Marshall NS, Bolger W, Gander PH. Abnormal sleep duration and motor vehicle crash risk. J Sleep Res 2004;13:177-8. (Pubitemid 38829900)
7. Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biological Psychiatry 1996;39:411-8. (Pubitemid 26124560)
8. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989;262:1479-84. (Pubitemid 19220042)
9. Mallon L, Broman JE, Hetta J, Mallon L, Broman J-E, Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population. Diabetes Care 2005;28:2762-7. (Pubitemid 43951172)
10. Panneman MJ, Goettsch WG, Kramarz P, Herings RM. The costs of benzodiazepine-associated hospital-treated fall injuries in the EU: a Pharmo sudy. Drugs Aging 2003;20:883-9.
11. Campbell SS, Broughton RJ. Rapid decline in body temperature before sleep: fluffing the physiological pillow? Chronobiol Int 1994;11:126-31.
12. Curran HV, Collins R, Fletcher S, Kee SC, Woods B, Illife S. Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychological Med 2003;33:1223-37. (Pubitemid 37265211)
13. Shapiro CM, Dement WC. Impact and epidemiology of sleep disorders. BMJ 1993;306:1604-7. (Pubitemid 23164912)
14. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
15. Rofail LM, Wong KH, Unger G, Marks GB, Grunstein RR. Comparison between a single-channel nasal airflow device and oximetry for the diagnosis of obstructive sleep apnea. Sleep 2010;33:1106-14.
16. National Institute for Health and Clinical Excellence. Continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypopnoea syndrome. NICE, 2008. http://guidance.nice.org.uk/TA139.
17. Cooke JR, Ancoli-Israel S. Normal and abnormal sleep in the elderly. Handb Clin Neurol 2011;98:653-5.
18. Arroll B, Goodyear-Smith F, Kerse N, Fishman T, Gunn J. Effect of the addition of a "help" question to two screening questions on specificity for diagnosis of depression in general practice: diagnostic validity study. BMJ 2005;331:884.
19. Puddifoot S, Arroll B, Goodyear-Smith FA, Kerse NM, Fishman TG, Gunn JM. A new case-finding tool for anxiety: a pragmatic diagnostic validity study in primary care. I J Psychiatry Med 2007;4:371-81. (Pubitemid 351468861)
20. Kroenke K, Spitzer RL, Williams BW, Lowe B. A ultra-brief screening scale for anxiety and depression: the PHQ 4. Psychosomatics 2009;50:613-21.
21. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70. (Pubitemid 13098606)
22. Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry 1974;131:1121-3.
23. Wennberg P, Escobar F, Espi F, Canteras M, Lairson DR, Harlow K, et al. The alcohol use disorders identification test (AUDIT): A psychometric evaluation. Reports Dept Psychol U Stockholm 1996;811:1-14.
24. WHO. The ASSIST project-Alcohol, Smoking and Substance Involvement Screening Test. 2011. www.who.int/substance-abuse/activities/assist/en/index. html.
25. Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S, et al. Stop questionnaire. A tool to screen patients for obstructive sleep apnea. Anesthesiology 2008;108:812-21. (Pubitemid 351589476)
26. Kayumov L, Brown, G, Jindal R, Buttoo K, Shapiro CM. A randomized, double-blind, placebo-controlled crossover study of the effect of exogenous melatonin on delayed sleep phase syndrome. Psychosom Med 2001;63:40-8. (Pubitemid 32125355)
27. Rosenthal NE, Joseph-Vanderpool JR, Levendosky AA, Johnston SH, Allen R, Kelly KA, et al. Phase-shifting effects of bright morning light as treatment for delayed sleep phase syndrome. Sleep 1990;13:354-61. (Pubitemid 20366853)
28. Best Practice. Insomnia. http://bestpractice.bmj.com/best-practice/ monograph/227.html.
29. Edinger JD, Olsen MK, Stechuchak KM, Means MK, Lineberger MD, Kirby A, et al. Cognitive behavioral therapy for patients with primary insomnia or insomnia associated predominantly with mixed psychiatric disorders: a randomized clinical trial. Sleep 2009;32:499-510.
30. Morgenthaler T, Kramer M, Alessi C, Friedman L, Boehlecke B, Brown T, et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American academy of sleep medicine report. Sleep 2006;29:1415-9. (Pubitemid 44764666)
31. Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL, et al. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004). Sleep 2006;29:1398-414.
32. Irwin MR, Cole JC, Nicassio PM. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health Psychology 2006;25:3-14.
33. Smith MT, Perlis ML, Park A, Smith MS, Pennington J, Giles DE, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2002;159:5-11. (Pubitemid 41070720)
34. Edinger JD, Sampson WS, Edinger JD, Sampson WS. A primary care "friendly" cognitive behavioral insomnia therapy. Sleep 2003;26:177-82. (Pubitemid 39610694)
35. Spielman AJ, Saskin P, Thorpy MJ. Treatment of chronic insomnia by restriction of time in bed. Sleep 1987;10:45-56.